BlueVoyant said to raise $68m in its Series C round

Cybersecurity company BlueVoyant has raised $68m in its new funding round, which was led by Temasek.

With the capital injection, the company will accelerate its growth plans. The firm will look to improve its managed security services, third-party cyber risk services and cyber defence services.

BlueVoyant is a cybersecurity company which helps businesses in the financial and business services, manufacturing, municipal government, healthcare and pharmaceutical, energy and utilities and the education sectors.

The company is a data analytics-driven cybersecurity company which helps protect businesses of all sizes from cyberattacks. It offers advanced threat intelligence, managed security services and professional services.

The cybersecurity company has offices in New York, Maryland, San Francisco, London, Madrid, Tel Aviv, the Philippines and has recently opened new offices in Central America.

With the close of the round, the company has raised a total of $275m in funding. Last year, the company bagged $82.5m in its expanded Series B round.

Contributions came from a selection of new and previous investors, including financial services technology developer Fiserv.

BlueVoyant co-founder, and CEO Jim Rosenthal said, “This latest round of funding will enable BlueVoyant to continue to service and build our ever-growing customer base, providing them with the most advanced cybersecurity defense capabilities.

“We are delighted to have generated such strong investor demand. This in turn helps us develop the managed services we offer; including combining our capabilities into our new Risk Operations Center to manage cyber risk for supply chains and investment portfolios. BlueVoyant has demonstrated its expertise and vision, identifying a clear market need for exceptional cybersecurity to defend both large and medium sized enterprises.”

Copyright © 2020 FinTech Global

Enjoying the stories?

Subscribe to our daily FinTech newsletter and get the latest industry news & research

Investors

The following investor(s) were tagged in this article.